China Pharma Files Prospectus Supplement With The U.S. SEC Under Which The Company May Offer And Sell From Time To Time Shares Of Common Stock, With An Aggregate Offering Price Of Up To $600,000

Benzinga · Dec 13 21:01

China Pharma Holdings, Inc. (NYSE:CPHI) ("China Pharma," or the "Company"), a specialty pharmaceutical company, today announced that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (the "SEC") under which the Company may offer and sell from time to time shares of common stock, par value $0.001 per share (the "Common Stock"), with an aggregate offering price of up to $600,000 (the "Financing").

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

China Pharma Files Prospectus Supplement With The U.S. SEC Under Which The Company May Offer And Sell From Time To Time Shares Of Common Stock, With An Aggregate Offering Price Of Up To $600,000

Risk Disclaimer